Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-02-12 GOEDDEL DAVID V Director Purchase +2,222,222 $4.50 $10.0M 13,599,275
2023-08-29 Hoey Timothy Chief Scientific Officer Sale 10b5-1 −7,243 $4.26 $31K 247,396
2023-08-16 Hoey Timothy Chief Scientific Officer Sale −4,007 $3.81 $15K 254,639
2023-08-16 Tingley Whittemore Chief Medical Officer Sale −5,563 $3.81 $21K 76,437
2023-08-16 PATTERSON LEONE D Chief Fin. and Bus. Officer Sale −4,452 $3.81 $17K 64,542
2023-08-16 Ali Faraz Chief Executive Officer Sale −5,563 $3.81 $21K 119,437
2023-06-09 Walsh Jeffrey T. Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Williams R Sanders Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Stehman-Breen Catherine Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Srivastava Deepak Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Parschauer Karah Herdman Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Lee June Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 GOEDDEL DAVID V Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 CHEN JIN-LONG Director Grant or award · Stock Option (Right to buy) +29,532 29,532
2023-06-09 Burroughs Amy L. Director Grant or award · Stock Option (Right to buy) +14,766 14,766
2023-03-10 COLUMN GROUP III GP, LP 10% owner Purchase +6,779 $2.60 $18K 11,377,053
2023-03-10 GOEDDEL DAVID V Director Purchase +6,779 $2.60 $18K 11,377,053
2023-02-15 Hoey Timothy Chief Scientific Officer Grant or award +30,000 228,646
2023-02-15 Hoey Timothy Chief Scientific Officer Grant or award +30,000 258,646
2023-02-15 Hoey Timothy Chief Scientific Officer Grant or award · Stock Option (Right to buy) +175,000 175,000

Page 8 of 12 · 228 trades